Kansas coach Bill Self released from hospital
Self, 62, had checked into Lawrence Memorial Hospital on Thursday after experiencing "some concerning symptoms" and feeling unwell. The school said he is expected to make a full recovery.
"I want to thank all the amazing doctors and nurses at LMH Health for the excellent care I received during my stay," Self said in a statement. "I feel strong and am excited to be home. Our team has had a productive summer, and I'm looking forward to recharging and preparing for the upcoming season."
Thursday marked the second heart-related procedure for Self in just more than two years. After being hospitalized because of chest tightness and concerns about his balance, he underwent a catheterization in March 2023 and had two stents put in to treat blocked arteries. The procedure forced him to miss the Big 12 and NCAA Tournaments that year as Kansas, a No. 1 seed, was ousted by No. 8 Arkansas in the second round.
Self, the winningest men's basketball coach in Jayhawks history, signed a $53 million contract in 2023, making him the highest-paid coach in college basketball.
He was inducted into the Naismith Memorial Basketball Hall of Fame in 2017 and is entering his 23rd season with Kansas. He has a 624-156 record there, winning two national titles.
Kansas will open its season Nov. 3 against Wisconsin-Green Bay.
--Field Level Media
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
8 minutes ago
- Daily Mail
Shedeur Sanders gets huge boost as rival Cleveland Browns QB Kenny Pickett injures with hamstring
Cleveland Browns quarterback Kenny Pickett will be sidelined because of a hamstring injury - potentially opening the door for Shedeur Sanders to stake his claim. The injury to Pickett is believed to have occurred during a red zone 11-on-11 drill late in Saturday's practice, multiple reports have suggested. Coach Kevin Stefanski is expected to address Pickett's status before Monday's practice. Pickett, 27, will be evaluated later in the week. The Browns have their first padded practice on Monday and go for three straight days until taking Thursday off and then practicing on Friday and Saturday. Pickett's injury means Sanders, who slid down into the fifth round of the NFL Draft earlier this year despite many considering him a top three selection, will get more reps. Until now, he has been maginalized with Joe Flacco and Pickett leading the race to be named the starting QB for the Browns. Dillon Gabriel, another quarterback the Browns drafted this year, is also in the running for the starting spot. Cleveland opens the season on Sept. 7 against Cincinnati. Pickett and Flacco have received most of the snaps with the first team during the first four days of practice. Gabriel got some first-team reps while Sanders' just began getting some second-team work Friday and Saturday. 'I'm not even going to think about that or have that even in my thought process of why it is,' Sanders said on Friday about practicing with the third and fourth team. 'It doesn't make me feel down or it doesn´t make me feel left out or anything because I know who I am as a person. I know who I am as an individual, and I know what I could bring to this team. 'I know whenever I get my opportunity, I've got to maximize it,' he said. 'I just got to think about what I could do to get better even if I´m not getting reps.' After struggling early in the week, Pickett had his best practice on Saturday that included a couple of touchdown passes in red zone drills. The coaching staff likes Pickett's mobility and the ability to create plays on the run. 'Coaches are looking for the guy that´s consistent, that´s the same guy every day that they can count on. They can call any play and they know that we´ll get them out of a bad play,' Pickett said on Thursday. 'If the shots called and it´s not there, we´ll check it down.' Pickett was acquired from Philadelphia in March. A 2022 first-round selection by Pittsburgh, Pickett has 25 career starts with 15 touchdowns and 14 interceptions.
The Sun
8 minutes ago
- The Sun
The most common side effects of different fat jabs revealed – as researchers find vomiting and nausea top symptom
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs. But the drugs can leave some users feeling seriously unwell and many in hospital. 2 After scouring social media, scientists have found the most common side effects of the popular fat-busting meds. Vomiting, nausea and headaches are the most talked-about side effects of the jabs, according to the new study, which analysed thousands of Facebook posts. The US researchers looked at how people in the US were discussing GLP-1 drugs like Wegovy, Ozempic, and Mounjaro on public pages. They found that gut issues were the most frequently mentioned side effects overall, especially among users of semaglutide (the active ingredient in Wegovy) and tirzepatide (the active ingredient in Mounjaro). Mental health concerns like anxiety and depression were also raised, but far less frequently. The study, published in JMIR Infodemiology, found that vomiting was most often mentioned in posts about Mounjaro, a drug containing tirzepatide, at 3.8 per cent. Meanwhile, Wegovy users mentioned depression more than any other group, with 1.57 per cent of posts referencing the symptom. The drugs, originally developed for type 2 diabetes, have soared in popularity thanks to their dramatic weight-loss effects, with celebs like Oprah Winfrey and Sharon Osbourne singing their praises. But they've also been linked to less glamorous side effects, such as joint pain, fatigue, hair loss, and in some cases, gallbladder problems. Despite the risks, experts say the drugs are still safe and effective for most patients. Weight Loss Jabs - Pros vs Cons They help control blood sugar, trigger rapid weight loss, and cut the risk of dying from heart disease by around a fifth in people with obesity or type 2 diabetes. Roughly 1.5million people in the UK are now taking GLP-1 drugs, which have been hailed by some as game-changers in the fight against obesity. In the US, this number is even higher, with over 2 per cent of the population, approximately 4 million people, currently using these medications for weight loss. But health officials warn they are not a silver bullet and can come with side effects. The scientists found these effects varied by brand. Zepbound, a newer tirzepatide drug which is approved in the US but not the UK, was linked more often to high blood pressure, While Ozempic posts mentioned gallbladder issues most. Ozempic is approved for weight loss in the US but is only approved for diabetes in the UK. Scientists from the University of Maryland, who are behind the study, analysed nearly 60,000 unique public Facebook posts uploaded by US users of the medicines between 2022 and 2024, They used cluster analysis to map out which symptoms were often mentioned together. They found that vomiting, nausea and pancreatitis - a condition where the pancreas becomes inflamed - often came hand in hand, while anxiety frequently appeared alongside depression and fatigue. Posts about side effects spiked after major events including the US Food and Drug Administration approving Wegovy for teens, celebrity endorsements, and wider insurance coverage in the US. 2 Despite these increases, the proportion of people talking about side effects actually dropped over time. Scientists say monitoring social media could be a useful way to spot side effects that might be missed or underreported in clinical trials. But they warned that Facebook posts don't tell the full story as symptoms were self-reported, which means they can be exaggerated or incomplete. There is also no way to verify dosage, how long people were on the drugs, or even whether they were using genuine products. However, the findings offer insight into what real-world users are experiencing, beyond the controlled world of clinical trials. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
The Independent
37 minutes ago
- The Independent
Ham salad brands recalled over listeria contamination fears
The U.S. Department of Agriculture's Food Safety and Inspection Service issued a public health warning for Reser's Fine Foods Ham Salad and Molly's Kitchen Ham Salad over listeria contamination fears. According to a press release from the agency, the possible contamination was discovered when a Reser's, based in Topeka, Kansas, was found to have used a breadcrumb product that was already subject to a Listeria monocytogenes recall. There have been no reports of illness among consumers due to contamination. The agency advises anybody who has consumed the products to seek medical help immediately. The specific warning is for 12-ounce plastic tubs of 'Reser's Fine Foods Ham Salad' with expiration dates of 09/01/2025 and 5-pound plastic tubs of 'Molly's Kitchen Ham Salad' with expiration dates of 08/31/2025. The FSIS warning raises concerns that retailers and consumers may have the product in their refrigerators and freezers. Customers are asked to be mindful and refrain from eating the named products. In May, a listeria outbreak linked to ready-to-eat sandwiches and snacks has sickened at least 10 people in the U.S. A producer is voluntarily recalling dozens of products sold to retail stores, hospitals, hotels, airports, and airlines, federal officials said. Listeria poisoning is caused by a particularly resilient type of bacteria that can survive and grow even during refrigeration. About 1,600 people are infected with it — and 260 die each year in the U.S., according to the CDC. Listeria bacteria thrive in moist environments, including soil, water, and decaying vegetation, and are carried by some animals. The hardy germs are typically spread when food is harvested, processed, transported or stored in places that are contaminated with the bacteria. When bacteria enter a food processing plant, they can be difficult to eradicate. Foods contaminated with the bacteria can cause people to become ill. Symptoms can be mild and include fever, muscle aches, nausea, vomiting, and diarrhea. More serious illnesses can include headache, stiff neck, confusion, loss of balance, and convulsions. Listeria poisoning is challenging because symptoms can develop quickly, within a few hours or days after consuming contaminated food. However, they can also take weeks or up to three months to appear. Those most vulnerable to getting sick include the very young, people older than 65, and those with weakened immune systems or who are pregnant. Listeria can survive and grow in refrigerated food. It can be killed by heating foods to 'steaming hot,' or 165 degrees Fahrenheit (74 degrees Celsius), the CDC says. But that's not always possible — or palatable—for foods that are made to be eaten cold. Because Listeria can survive under refrigeration, it's essential to clean and sanitize any surfaces, including refrigerator drawers and shelves, that may have come into contact with the products.
